Breaking News

Aesica Expands Oral Solids Capabilities

July 9, 2014

Adds roller compaction unit at Zwickau site

Aesica Pharmaceuticals has added services to its oral solids capability with a new roller compaction unit for dry granulation production in Zwickau, Germany. The roller compaction unit uses a continuous production step designed to enhance product uniformity for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.
 
This represents the company’s latest investment in the region, including a new tablet coater capability and pouch packing line.
 
Ian Muir, managing director, Finished Dose at Aesica, said, “This new investment aligns with our strategy of investing in our German sites to broaden capabilities, which is expanding our domestic market share within Germany, whilst allowing us to offer new services to our global customers. The dry granulation capability will drive business growth as customers with moisture sensitive APIs seek appropriate technologies, and crucially, experienced CDMOs that can deliver their products.”

Related Contract Manufacturing:

Related Packaging:

blog comments powered by Disqus
  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO